Tweets
Maksymowych et al. RCT ofAdalimumab for knee OA!? it doesn't work. @RheumNow #ACR22 Abstr#1891 https://t.co/pfPVJ9A1Ex https://t.co/X7sLEaqGvT
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
@RheumNow video live from #ACR22
Ab0675: Diffuse alveolar hemorrhage in APLS
https://t.co/8BDyxzAGJ2
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
What’s new w #classification for #APS? You don’t have to have 2 positive tests disseminated in time. BUT remember the the labs for anticardiolipin are shockingly variable btwn centres. @RheumNow #ACR22 https://t.co/NTqQ6h7fws
Janet Pope @Janetbirdope ( View Tweet )
3 years 8 months ago
Abstract #PP25
Patient mantra on life with SpA: “not to over-exert the body on your good days and always strive to be active on your bad days”
Patient recommended exercise:
🏓table tennis
🏊♂️swimming
🧘yoga
🤸tai chi
#ACR22 @RheumNow
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 8 months ago
Staggering stats after a #osteoporosis hip fracture!
40% cannot walk independently
30% have a permanent disability
20% mortality in surgically fixed hip
40% mortality if not surgically fixed. -Dr. M Humphrey #ACR22 @rheumnow https://t.co/DSYQjDw6pW
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
Dose Matters!
Steroid doses as little as 2.5 mg/day when taken chronically increase risk for fractures #ACR22 @rheumnow https://t.co/fIocJtebkI
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
Morales et al. AUR200, novel BAFF/APRIL inhibitor. Looking promising in pre-clinical and animal models. We will wait and see! @RheumNow #ACR22 Abstr#1629 https://t.co/htmX2GHV3X https://t.co/jvhFdx2c52
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
MOA of how steroids cause #osteoporosis #ACR22 @rheumnow https://t.co/k6MvftH4AV
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
Lin et al. Genetic risk (HR 2.3 women, 2.63 men) and lifestyle (HR 5.7 for women, 3.7 for men) both individual contributors and synergistic (HR 9.1 women, 8.7 men) in gout development in both men and women. Modifiable! @RheumNow #ACR22 Abstr#1633 https://t.co/51KPgfXn1w https://t.co/gOU7DfOKvt
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
PMR is no a disease of vague shoulder and hip pain.
It's something much more specific:
a chronic inflammatory disease of musculotendinous structures.
We're starting to understand the real story.
@drceowen lays it out for #ACR22 this morning
@EBRheum @SattuiSEMD @RheumNow https://t.co/thqtCwSULM
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
Bimekizumab (BKZ) in AxSpA to Wk52
◦ sustained efficacy
◦ suppression of inflammation
◦ improvements in function and quality of life
◦ no new safety signals were observed
◦ consistent with the safety profileWk24 data
Baraliakos #L14 https://t.co/gk23g4vqQl #ACR22 @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 8 months ago
Fernandes et al. CPPD assoc increased nephrolithiasis. 8.06% vs 4.88%; p<0.0001. @RheumNow #ACR22 Abstr#1819 https://t.co/o8Afmcc429 https://t.co/3EoOXpqpGN
Richard Conway @RichardPAConway ( View Tweet )
3 years 8 months ago
